Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

Accretive Health

(AH)

numbers boosted at Goldman. Shares of AH now seen reaching $14, according to Goldman Sachs. Estimates also upped, given better visibility into the company's backlog. Neutral rating.

AIG

(AIG) - Get Report

target raised at UBS to $53. Warrants have jumped in value, as has the company's stake in MET. Neutral rating.

Baker Hughes

(BHI)

price target boosted at Barclays to $63 from $52. International E&P spending is estimated to rise 12% in 2011 and industry is in early stages of long international upcycle, Barclays said. Maintain Equal Weight rating.

BMC Software

(BMC)

target raised at Goldman. Shares of BMC now seen reaching $49, according to Goldman Sachs. Company should benefit from a better macro outlook. Neutral rating.

Broadcom

(BRCM)

estimates cut at Goldman through 2012. Company is facing higher acquisition costs. Buy rating and $48 price target.

Caterpillar

(CAT) - Get Report

estimates, target upped at RBC. CAT estimates were boosted through 2012, RBC Capital said. Company is seeing higher demand, especially in the mining sector. Outperform rating and new $108 price target.

Cubist Pharmaceuticals

(CBST)

estimates cut at Oppenheimer through 2011. Company cut guidance for Cubicin. Perform rating.

Charles River

(CRL) - Get Report

estimates reduced at Morgan Stanley through 2012. Company can't cut costs fast enough to keep up with lower sales. Equal-weight rating.

Diamond Offshore Drilling

(DO) - Get Report

price target increased at Barclays to $69 from $62. International E&P spending is estimated to rise 12% in 2011 and industry is in early stages of long international upcycle, Barclays said. Maintain Equal Weight rating.

First Solar

(FSLR) - Get Report

price target boosted at Credit Suisse to $137 from $127.50 on strong guidance, Credit Suisse said. Maintain Neutral rating.

First Solar

(FSLR) - Get Report

numbers raised at UBS. Shares of FSLR now seen reaching $160, according to UBS. Estimates also increased, to match the company's new guidance. Buy rating.

General Electric

(GE) - Get Report

target upped at Goldman to $21. Credit losses appear to have bottomed. Buy rating.

Halliburton

(HAL) - Get Report

price target higher at Barclays. HAL price target improved to $58 from $53. International E&P spending is estimated to rise 12% in 2011 and industry is in early stages of long international upcycle, Barclays said. Maintain Overweight rating.

Helmerich & Payne

(HP) - Get Report

price target lifted at Barclays. HP price target improved to $57 from $43. International E&P spending is estimated to rise 12% in 2011 and industry is in early stages of long international upcycle, Barclays said. Maintain Equal Weight rating.

Intuitive Surgical

(ISRG) - Get Report

target lowered at Goldman to $220, according to Goldman Sachs. Recent channel checks suggest lower sales. Sell rating.

Kennametal

(KMT) - Get Report

estimates, target increased at BB&T. KMT estimates were raised through 2013, BB&T said. November orders remained strong. Buy rating and new $47 price target.

LSI

(LSI) - Get Report

estimates, target boosted at UBS. Shares of LSI now seen reaching $6, according to UBS. Estimates also upped, given stabilizing end-market demand. Neutral rating.

Morgan Stanley

(MS) - Get Report

estimates reduced at Goldman through 2012. Company will likely be hurt by fixed-income trading. Neutral rating and $30 price target.

Occidental Petroleum

(OXY) - Get Report

numbers raised at Goldman. Shares of OXY now seen reaching $105. Company has made several strategic transactions and is boosting its dividend. Buy rating.

Pepsi

(PEP) - Get Report

estimates lowered at UBS through 2011. Company will continue to be hurt by its portfolio transition. Buy rating and $76 price target.

Rackspace

(RAX)

estimates, target boosted at Kaufman. Shares of RAX now seen reaching $35, according to Kaufman Bros. Estimates also upped, as the company should continue to see solid demand for its outsourced services. Buy rating.

Schlumberger

(SLB) - Get Report

price target increased at Barclays. SLB price target lifted to $102 from $81. International E&P spending is estimated to rise 12% in 2011 and industry is in early stages of long international upcycle, Barclays said. Maintain Overweight rating.

This article was written by a staff member of TheStreet.